Pembrolizumab in Combination With R-ICE Chemotherapy in Relapsed/Refractory Diffuse Large B-cell Lymphoma
Clinical trial NCT05221645 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05221645
- Sponsor
- University of Southampton
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-27
- Primary completion
- 2026-05-30
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.